Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Next-generation Sequencing03:00

Next-generation Sequencing

100.8K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
100.8K
Sanger Sequencing01:57

Sanger Sequencing

777.7K
DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...
777.7K
Genomics02:02

Genomics

41.7K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
41.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Experiences With Detection of Higher-Copy Sex Chromosome Aneuploidy by cfDNA Screening: The Critical Role of Diagnostic Testing.

American journal of medical genetics. Part A·2026
Same author

Universal Presence of Gene/Variant Nomenclature Errors in Journal Manuscript Submissions.

Clinical chemistry·2026
Same author

Response to Deuitch et al.

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same author

Scaling genomic reanalysis to unlock diagnoses and transform rare disease care.

HGG advances·2026
Same author

Symposium report-ethical and social considerations regarding return of secondary findings in atomic bomb survivors.

Carcinogenesis·2025
Same author

ACMG SF v3.3 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).

Genetics in medicine : official journal of the American College of Medical Genetics·2025

Related Experiment Video

Updated: Mar 22, 2026

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
05:51

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

26.6K

A Clinician's perspective on clinical exome sequencing.

Anne H O'Donnell-Luria1,2,3, David T Miller4,5,6

  • 1Division of Genetics and Genomics, Boston Children's Hospital, 300 Longwood Ave., Hunnewell 5, Boston, MA, 02115, USA.

Human Genetics
|April 30, 2016
PubMed
Summary

Clinical exome sequencing significantly improves molecular genetic diagnoses for rare disorders. This advanced technology shortens lengthy diagnostic odysseys, benefiting patients, families, and healthcare teams.

More Related Videos

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

35.0K
Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
11:02

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

20.0K

Related Experiment Videos

Last Updated: Mar 22, 2026

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
05:51

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

26.6K
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

35.0K
Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
11:02

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

20.0K

Area of Science:

  • Genetics
  • Molecular Biology
  • Clinical Diagnostics

Background:

  • Many patients with rare genetic disorders face prolonged diagnostic odysseys without a specific molecular diagnosis.
  • Challenges in diagnosing genetic disorders include phenotypic and genetic heterogeneity, and limitations of traditional testing.
  • Complex cases, such as blended phenotypes from multiple monogenic disorders, pose significant diagnostic dilemmas.

Purpose of the Study:

  • To highlight the impact of clinical exome sequencing on improving diagnostic yield for various disorders.
  • To emphasize the reduction in diagnostic odyssey duration through advanced sequencing technologies.
  • To outline the benefits of clinical exome sequencing for patients, families, and healthcare providers.

Main Methods:

  • Utilizing clinical exome sequencing (CES) as a primary diagnostic tool.
  • Applying advanced sequencing technologies to identify genetic causes of disorders.
  • Analyzing patient data to overcome challenges posed by phenotypic and genetic heterogeneity.

Main Results:

  • CES has substantially improved the ability to identify the genetic cause of a wide range of disorders.
  • A higher proportion of patients are receiving molecular diagnoses compared to previous methods.
  • The time required for diagnosis has been significantly reduced, shortening the diagnostic odyssey.

Conclusions:

  • Clinical exome sequencing is a powerful tool for diagnosing rare genetic disorders, even in complex cases.
  • The technology offers significant advantages by increasing diagnostic accuracy and reducing the time to diagnosis.
  • CES provides crucial benefits for the healthcare team, patients, and their families by offering timely answers and enabling appropriate management.